Published in Br J Clin Pharmacol on May 01, 2004
Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev (2011) 5.30
Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomised controlled trials. BMJ (2006) 3.68
A comprehensive view of sex-specific issues related to cardiovascular disease. CMAJ (2007) 2.35
Bias in observational studies of prevalent users: lessons for comparative effectiveness research from a meta-analysis of statins. Am J Epidemiol (2012) 1.76
Predictors of nonadherence to statins: a systematic review and meta-analysis. Ann Pharmacother (2010) 1.66
Cytochrome P450 and gene activation--from pharmacology to cholesterol elimination and regression of atherosclerosis. Eur J Clin Pharmacol (2008) 1.52
Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator. Genet Epidemiol (2016) 1.35
Genetic variability within the cholesterol lowering pathway and the effectiveness of statins in reducing the risk of MI. Atherosclerosis (2011) 1.27
An update on the lipid nephrotoxicity hypothesis. Nat Rev Nephrol (2009) 1.17
A novel programme to evaluate and communicate 10-year risk of CHD reduces predicted risk and improves patients' modifiable risk factor profile. Int J Clin Pract (2008) 1.16
Statin use and musculoskeletal pain among adults with and without arthritis. Am J Med (2012) 1.09
Methodological issues in current antipsychotic drug trials. Schizophr Bull (2008) 1.07
Lipids and carotid plaque in the Northern Manhattan Study (NOMAS). BMC Cardiovasc Disord (2009) 1.04
Does pravastatin promote cancer in elderly patients? A meta-analysis. CMAJ (2007) 0.98
The effect of nine common polymorphisms in coagulation factor genes (F2, F5, F7, F12 and F13 ) on the effectiveness of statins: the GenHAT study. Pharmacogenet Genomics (2009) 0.91
Sex differences in the effectiveness of statins after myocardial infarction. CMAJ (2007) 0.90
Accounting for clinical action reduces estimates of gender disparities in lipid management for diabetic veterans. J Gen Intern Med (2013) 0.85
Prevention of cardiovascular diseases: focus on modifiable cardiovascular risk. Heart (2005) 0.82
The "Statinth" wonder of the world: a panacea for all illnesses or a bubble about to burst. J Negat Results Biomed (2005) 0.82
Decision-making using absolute cardiovascular risk reduction and incremental cost-effectiveness ratios: a case study. Cardiovasc J Afr (2008) 0.81
Predictors of long-term mortality in new start statin users. J Drug Assess (2015) 0.78
Using imputed pre-treatment cholesterol in a propensity score model to reduce confounding by indication: results from the multi-ethnic study of atherosclerosis. BMC Med Res Methodol (2013) 0.78
HMG-CoA reductase inhibitors in kidney transplant recipients receiving tacrolimus: statins not associated with improved patient or graft survival. BMC Nephrol (2010) 0.77
Blood cholesterol trends 2001-2011 in the United States: analysis of 105 million patient records. PLoS One (2013) 0.77
Randomized controlled trial of the effect of phytosterols-enriched low-fat milk on lipid profile in Chinese. Sci Rep (2017) 0.75
The effects of pravastatin on the normal human placenta: Lessons from ex-vivo models. PLoS One (2017) 0.75
Pharmacogenetics of cardiovascular drug therapy. Clin Cases Miner Bone Metab (2009) 0.75
Therapy of hearing disorders - conservative procedures. GMS Curr Top Otorhinolaryngol Head Neck Surg (2005) 0.75
Competing demands and opportunities in primary care. Can Fam Physician (2017) 0.75
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet (2002) 44.28
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet (1994) 40.72
Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med (1995) 28.35
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med (1996) 23.76
Cardiovascular disease risk profiles. Am Heart J (1991) 21.65
Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care (1998) 18.69
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet (2002) 17.19
Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ (2003) 11.21
Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension (1995) 10.38
Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials. JAMA (1999) 9.18
Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA (2001) 9.16
Carcinogenicity of lipid-lowering drugs. JAMA (1996) 7.04
The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts. N Engl J Med (1997) 5.19
Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial. JAMA (2002) 4.94
Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA (2002) 4.91
Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Prospective studies collaboration. Lancet (1996) 3.95
Treatment with atorvastatin to the National Cholesterol Educational Program goal versus 'usual' care in secondary coronary heart disease prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study. Curr Med Res Opin (2002) 3.12
Deaths due to accidents and violence in two recent trials of cholesterol-lowering drugs. Arch Intern Med (1990) 3.02
Gauging the impact of statins using number needed to treat. JAMA (1999) 2.89
Effect of fluvastatin on ischaemia following acute myocardial infarction: a randomized trial. Eur Heart J (2002) 1.63
Cross sectional survey of effectiveness of lipid lowering drugs in reducing serum cholesterol concentration in patients in 17 general practices. BMJ (2003) 1.57
Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men. Am J Cardiol (1996) 1.55
Effect of pravastatin on coronary disease events in subgroups defined by coronary risk factors: the Prospective Pravastatin Pooling Project. Circulation (2000) 1.51
Effect of simvastatin on ischemic signs and symptoms in the Scandinavian simvastatin survival study (4S). Am J Cardiol (1998) 1.32
Coronary heart disease in patients with diabetes. N Engl J Med (2000) 1.22
A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty; final results of the fluvastatin angiographic restenosis (FLARE) trial. Eur Heart J (1999) 1.07
Dementia and statins. Lancet (2001) 0.81
Should decisions on treatment be based on absolute benefit rather than absolute risk? N Z Med J (2001) 0.78
Effectiveness of lipid lowering drugs in general practice: study had two major flaws. BMJ (2003) 0.78
Tissue Doppler echocardiographic evidence of reverse remodeling and improved synchronicity by simultaneously delaying regional contraction after biventricular pacing therapy in heart failure. Circulation (2002) 4.02
Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment. J Am Coll Cardiol (2004) 2.77
Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation (2005) 2.66
The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) Study. Circulation (2013) 2.64
Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet (2003) 2.59
Predictors of left ventricular reverse remodeling after cardiac resynchronization therapy for heart failure secondary to idiopathic dilated or ischemic cardiomyopathy. Am J Cardiol (2003) 2.53
Dabigatran versus warfarin: effects on ischemic and hemorrhagic strokes and bleeding in Asians and non-Asians with atrial fibrillation. Stroke (2013) 2.52
Frequent premature atrial complexes predict new occurrence of atrial fibrillation and adverse cardiovascular events. Europace (2011) 2.41
Prospective randomized trial of direct endomyocardial implantation of bone marrow cells for treatment of severe coronary artery diseases (PROTECT-CAD trial). Eur Heart J (2007) 2.11
Low-dose aspirin increases aspirin resistance in patients with coronary artery disease. Am J Med (2005) 2.08
Transmural action potential and ionic current remodeling in ventricles of failing canine hearts. Am J Physiol Heart Circ Physiol (2002) 2.00
Prevention of atrial fibrillation recurrence by statin therapy in patients with lone atrial fibrillation after successful cardioversion. Am J Cardiol (2003) 1.90
Proarrhythmic risk of embryonic stem cell-derived cardiomyocyte transplantation in infarcted myocardium. Heart Rhythm (2010) 1.89
C-reactive protein promotes cardiac fibrosis and inflammation in angiotensin II-induced hypertensive cardiac disease. Hypertension (2010) 1.85
Avoidance of right ventricular pacing in cardiac resynchronization therapy improves right ventricular hemodynamics in heart failure patients. J Cardiovasc Electrophysiol (2007) 1.75
Acute results of transvenous cryoablation of supraventricular tachycardia (atrial fibrillation, atrial flutter, Wolff-Parkinson-White syndrome, atrioventricular nodal reentry tachycardia). J Cardiovasc Electrophysiol (2002) 1.72
Bioartificial sinus node constructed via in vivo gene transfer of an engineered pacemaker HCN Channel reduces the dependence on electronic pacemaker in a sick-sinus syndrome model. Circulation (2006) 1.70
Incidence, clinical characteristics and outcome of congestive heart failure as the initial presentation in patients with primary hyperthyroidism. Heart (2006) 1.69
Transient atrial fibrillation complicating acute inferior myocardial infarction: implications for future risk of ischemic stroke. Chest (2007) 1.66
The incremental benefit of rate-adaptive pacing on exercise performance during cardiac resynchronization therapy. J Am Coll Cardiol (2005) 1.59
Oral arsenic trioxide-based maintenance regimens for first complete remission of acute promyelocytic leukemia: a 10-year follow-up study. Blood (2011) 1.58
MR diffusion tensor imaging study of postinfarct myocardium structural remodeling in a porcine model. Magn Reson Med (2007) 1.57
Intravenous diltiazem is superior to intravenous amiodarone or digoxin for achieving ventricular rate control in patients with acute uncomplicated atrial fibrillation. Crit Care Med (2009) 1.56
Upgrading pacemaker patients with right ventricular apical pacing to right ventricular septal pacing improves left ventricular performance and functional capacity. J Cardiovasc Electrophysiol (2009) 1.55
Reduction of C-reactive protein with isoflavone supplement reverses endothelial dysfunction in patients with ischaemic stroke. Eur Heart J (2008) 1.55
Temporary leadless pacing in heart failure patients with ultrasound-mediated stimulation energy and effects on the acoustic window. Heart Rhythm (2009) 1.52
Subclinical left ventricular dysfunction revealed by circumferential 2D strain imaging in patients with coronary artery disease and fragmented QRS complex. Heart Rhythm (2012) 1.52
Role of circulating endothelial progenitor cells in patients with rheumatoid arthritis with coronary calcification. J Rheumatol (2010) 1.52
Regulation of voltage-gated cardiac sodium current by epidermal growth factor receptor kinase in guinea pig ventricular myocytes. J Mol Cell Cardiol (2006) 1.51
Habitual physical activity is associated with endothelial function and endothelial progenitor cells in patients with stable coronary artery disease. Eur J Cardiovasc Prev Rehabil (2009) 1.51
The role of European national journals in education. Heart (2009) 1.46
A community study of sleep-disordered breathing in middle-aged Chinese women in Hong Kong: prevalence and gender differences. Chest (2004) 1.46
Clinical characteristics of and long-term outcome in Chinese patients with hypertrophic cardiomyopathy. Am J Med (2004) 1.45
Relationship between ventricular dyssynchrony and T-wave alternans in patients with coronary artery disease. Pacing Clin Electrophysiol (2011) 1.43
Relationship of circulating endothelial progenitor cells to the recurrence of atrial fibrillation after successful conversion and maintenance of sinus rhythm. Europace (2009) 1.42
Prevalence, awareness, treatment, and control of hypertension: United States National Health and Nutrition Examination Survey 2001-2002. J Clin Hypertens (Greenwich) (2006) 1.41
Effect of coronary sinus electrode on the optimal atrial defibrillation pathway for an atrioventricular defibrillator. J Cardiovasc Electrophysiol (2003) 1.41
Randomized controlled trial of vitamin D supplement on endothelial function in patients with type 2 diabetes. Atherosclerosis (2012) 1.39
Paracrine effects of direct intramyocardial implantation of bone marrow derived cells to enhance neovascularization in chronic ischaemic myocardium. Eur J Heart Fail (2007) 1.36
Pulmonary vein isolation using transvenous catheter cryoablation for treatment of atrial fibrillation without risk of pulmonary vein stenosis. J Am Coll Cardiol (2003) 1.36
A rare cause of infective endocarditis; Lactococcus garvieae. Int J Cardiol (2006) 1.34
Characterization of multiple ion channels in cultured human cardiac fibroblasts. PLoS One (2009) 1.33
Characterization of ionic currents in human mesenchymal stem cells from bone marrow. Stem Cells (2005) 1.32
Hemodynamic changes in hyperthyroidism-related pulmonary hypertension: a prospective echocardiographic study. J Clin Endocrinol Metab (2007) 1.30
Electrophysiological effects of a single intravenous administration of ivabradine (S 16257) in adult patients with normal baseline electrophysiology. Drugs R D (2003) 1.30
The effect of health-related quality of life (HRQOL) on health service utilisation of a Chinese population. Soc Sci Med (2002) 1.29
A short course of cardiac rehabilitation program is highly cost effective in improving long-term quality of life in patients with recent myocardial infarction or percutaneous coronary intervention. Arch Phys Med Rehabil (2004) 1.26
Heterogeneity of sodium current in atrial vs epicardial ventricular myocytes of adult guinea pig hearts. J Mol Cell Cardiol (2002) 1.25
Regulation of cell proliferation by intermediate-conductance Ca2+-activated potassium and volume-sensitive chloride channels in mouse mesenchymal stem cells. Am J Physiol Cell Physiol (2008) 1.22
Electrophysiological properties of pluripotent human and mouse embryonic stem cells. Stem Cells (2005) 1.17
Differential effects of tyrosine kinase inhibitors on volume-sensitive chloride current in human atrial myocytes: evidence for dual regulation by Src and EGFR kinases. J Gen Physiol (2004) 1.15
New-onset heart failure after permanent right ventricular apical pacing in patients with acquired high-grade atrioventricular block and normal left ventricular function. J Cardiovasc Electrophysiol (2007) 1.13
Ionic current abnormalities associated with prolonged action potentials in cardiomyocytes from diseased human right ventricles. Heart Rhythm (2004) 1.12
A new ECG criterion to identify takotsubo cardiomyopathy from anterior myocardial infarction: role of inferior leads. Heart Vessels (2009) 1.12
Ion channels in mesenchymal stem cells from rat bone marrow. Stem Cells (2006) 1.09
Aspirin resistance and adverse clinical events in patients with coronary artery disease. Am J Med (2007) 1.08
Acacetin, a natural flavone, selectively inhibits human atrial repolarization potassium currents and prevents atrial fibrillation in dogs. Circulation (2008) 1.07
No evidence of automatic atrial overdrive pacing efficacy on reduction of paroxysmal atrial fibrillation. Europace (2007) 1.07
Functional ion channels in mouse bone marrow mesenchymal stem cells. Am J Physiol Cell Physiol (2007) 1.06
Study of myocardial fiber pathway using magnetic resonance diffusion tensor imaging. Magn Reson Imaging (2007) 1.05
Prevalence of the metabolic syndrome in the United States National Health and Nutrition Examination Survey 1999-2002 according to different defining criteria. J Clin Hypertens (Greenwich) (2006) 1.05
Safety of catheter-based intramyocardial autologous bone marrow cells implantation for therapeutic angiogenesis. Am J Cardiol (2006) 1.03
Oral arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia. Blood (2003) 1.03
Rhythm vs. rate control of atrial fibrillation meta-analysed by number needed to treat. Br J Clin Pharmacol (2005) 1.03
Clinical implications of precordial ST-segment elevation in acute inferoposterior myocardial infarction caused by proximal right coronary artery occlusion. Clin Cardiol (2007) 1.01
Calcium-activated transient outward chloride current and phase 1 repolarization of swine ventricular action potential. Cardiovasc Res (2003) 1.00
Alleviation of pulmonary hypertension by cardiac resynchronization therapy is associated with improvement in central sleep apnea. Pacing Clin Electrophysiol (2008) 0.98
Successful treatment of relapsed acute promyelocytic leukemia in a patient receiving continuous ambulatory peritoneal dialysis with oral arsenic trioxide. Arch Intern Med (2005) 0.98
Clinical role of beta-lactam/beta-lactamase inhibitor combinations. Drugs (2003) 0.98
Electrocardiographic algorithm to identify the optimal target ablation site for idiopathic right ventricular outflow tract ventricular premature contraction. Europace (2009) 0.98
First human demonstration of cardiac stimulation with transcutaneous ultrasound energy delivery: implications for wireless pacing with implantable devices. J Am Coll Cardiol (2007) 0.97
Reversal of mitochondrial dysfunction by coenzyme Q10 supplement improves endothelial function in patients with ischaemic left ventricular systolic dysfunction: a randomized controlled trial. Atherosclerosis (2011) 0.97
Attenuation of left ventricular adverse remodeling with epicardial patching after myocardial infarction. J Card Fail (2010) 0.97
Effect of exercise training on vascular endothelial function in patients with stable coronary artery disease: a randomized controlled trial. Eur J Prev Cardiol (2011) 0.97
The membrane permeable calcium chelator BAPTA-AM directly blocks human ether a-go-go-related gene potassium channels stably expressed in HEK 293 cells. Biochem Pharmacol (2007) 0.96
Area of left ventricular regional conduction delay and preserved myocardium predict responses to cardiac resynchronization therapy. J Cardiovasc Electrophysiol (2005) 0.95
Triiodothyronine promotes cardiac differentiation and maturation of embryonic stem cells via the classical genomic pathway. Mol Endocrinol (2010) 0.95
Mechanistic role of I(f) revealed by induction of ventricular automaticity by somatic gene transfer of gating-engineered pacemaker (HCN) channels. Circulation (2007) 0.94
Association of subclinical myocardial injury with arterial stiffness in patients with type 2 diabetes mellitus. Cardiovasc Diabetol (2013) 0.93
Omega-3 polyunsaturated fatty acids inhibit transient outward and ultra-rapid delayed rectifier K+currents and Na+current in human atrial myocytes. Cardiovasc Res (2008) 0.92
Catheter ablation of atrial fibrillation via superior approach in patients with interruption of the inferior vena cava. Heart Rhythm (2008) 0.92
ROCK inhibition facilitates the generation of human-induced pluripotent stem cells in a defined, feeder-, and serum-free system. Cell Reprogram (2010) 0.92
Therapeutic angiogenesis with bone marrow--derived stem cells. J Cardiovasc Pharmacol Ther (2007) 0.92
Time course of esophageal lesions after catheter ablation with cryothermal and radiofrequency ablation: implication for atrio-esophageal fistula formation after catheter ablation for atrial fibrillation. J Cardiovasc Electrophysiol (2007) 0.92
The CHADS2 and CHA 2DS 2-VASc scores predict new occurrence of atrial fibrillation and ischemic stroke. J Interv Card Electrophysiol (2013) 0.91
Mast cell contributes to cardiomyocyte apoptosis after coronary microembolization. J Histochem Cytochem (2005) 0.91
Multiple Ca2+ signaling pathways regulate intracellular Ca2+ activity in human cardiac fibroblasts. J Cell Physiol (2010) 0.91
Effects of ventricular rate regularization pacing on quality of life and symptoms in patients with atrial fibrillation (Atrial fibrillation symptoms mediated by pacing to mean rates [AF SYMPTOMS study]). Am J Cardiol (2004) 0.91
Regional left ventricle mechanical asynchrony in patients with heart disease and normal QRS duration: implication for biventricular pacing therapy. Pacing Clin Electrophysiol (2003) 0.91
Effects of temporal application parameters on lesion dimensions during transvenous catheter cryoablation. J Cardiovasc Electrophysiol (2005) 0.90
Properties of ion channels in rabbit mesenchymal stem cells from bone marrow. Biochem Biophys Res Commun (2006) 0.90
Both EGFR kinase and Src-related tyrosine kinases regulate human ether-à-go-go-related gene potassium channels. Cell Signal (2008) 0.90
Daily intake of thiamine correlates with the circulating level of endothelial progenitor cells and the endothelial function in patients with type II diabetes. Mol Nutr Food Res (2008) 0.89
Effects of oral arsenic trioxide therapy on QT intervals in patients with acute promyelocytic leukemia: implications for long-term cardiac safety. Blood (2006) 0.89
Regression of left ventricular hypertrophy after treatment of hypertension: comparison of directed M-echocardiography with magnetic resonance imaging in quantification of serial mass changes. J Card Fail (2003) 0.89
Incidence and predictors of upper gastrointestinal bleeding in patients receiving low-dose aspirin for secondary prevention of cardiovascular events in patients with coronary artery disease. World J Gastroenterol (2006) 0.89
Characterization of ion channels in human preadipocytes. J Cell Physiol (2009) 0.88
Effect of herbal consumption on time in therapeutic range of warfarin therapy in patients with atrial fibrillation. J Cardiovasc Pharmacol (2011) 0.88